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OBJECTIVES The study was done to determine whether coronary steal (defined as an absolute decrease in
perfusion from resting blood flow) is induced by intravenous (IV) dipyridamole in patients
with severe coronary artery disease (CAD).
BACKGROUND Myocardial ischemia during coronary vasodilation is usually attributed to coronary steal.
However, there is limited data on the absolute magnitude of coronary steal in humans.
METHODS Eighteen patients with multivessel CAD underwent dynamic positron emission tomography
(PET) imaging with 13NH3 at rest and after infusion of IV dipyridamole. Eight myocardial
sectors were analyzed per short axis slice and myocardial blood flow calculated with a
two-compartment model in absolute terms.
RESULTS Coronary steal occurred in 8 of the 18 patients. In the 8 patients with coronary steal,
myocardial blood flow decreased from 90 6 18 ml/100 g/min at rest to 68 6 27 ml/100 g/min
following dipyridamole in the segments with steal, and increased from 87 6 19 to 138 6 16
ml/100 g/min following dipyridamole in the segments without steal. Significant clinical
correlates of coronary steal were either ST elevation or the combination of ST depression and
angina.
CONCLUSIONS Coronary vasodilation with IV dipyridamole is associated with significant reductions in blood
flow to collateral-dependent myocardium consistent with coronary steal in about 45% of
patients with severe CAD. (J Am Coll Cardiol 2001;37:109–16) © 2001 by the American
College of Cardiology
Perfusion imaging during coronary vasodilation with either
adenosine or dipyridamole is widely used for the diagnosis
of coronary artery disease (CAD) (1–3). Dipyridamole, by
increasing endogenous adenosine levels, induces coronary
vasodilation (4,5). In experimental studies, absolute flow is
increased, even in territories distal to stenoses, when collat-
eral circulation is not present (6,7). Nonetheless, myocardial
ischemia (defined as an imbalance between myocardial
perfusion and demand) is believed to occur in some patients
with CAD following dipyridamole. Because dipyridamole
does not usually increase myocardial oxygen demand, it
causes ischemia, mainly by decreasing flow to collateral-
dependent vascular beds through “coronary steal” (8–12).
Coronary steal is conventionally defined as an absolute
decrease in perfusion, compared to resting flow, to collat-
eralized myocardium following coronary vasodilation (12).
It is caused by redistribution of flow away from collateral-
dependent myocardium following coronary vasodilation be-
cause of a fall in resistance in the supply artery diverting flow
away from the collateral bed, which is already near maximal
vasodilation (13). Thus, the driving pressure at the head of
the collateralized bed decreases and reduces distal perfusion.
Myocardial ischemia due to coronary steal is generally
believed to be manifested clinically by ST segment depres-
sion following coronary vasodilation (13,14). Although
coronary steal has been well described in canine studies
(15,16), there are more limited observations of the absolute
magnitude of coronary steal in humans and its relationship
to clinical signs of myocardial ischemia. In addition, there is
controversy whether chest pain and electrocardiographic
(ECG) changes with coronary vasodilation represent true
myocardial ischemia because of coronary steal. Thus, the
goal of this study was to evaluate whether dipyridamole
induces absolute flow reductions in collateralized myocar-
dium in patients with multivessel disease, and to determine
whether any clinical signs or symptoms correlate with the
occurrence of myocardial ischemia due to steal.
METHODS
The study was approved by the Institutional Review Board
of the Columbia-Presbyterian Medical Center, and written
informed consent was obtained. Eighteen patients (15 men,
3 women) with severe multivessel coronary artery disease
(double vessel disease in 4 and triple vessel disease in 14
patients) as assessed by coronary angiography performed
within six months of enrollment underwent quantitative
positron emission tomography (PET) imaging at rest and
again following induction of hyperemia with intravenous
(IV) dipyridamole. No cardiac events occurred between the
angiogram and the PET study. Absolute blood flow levels
(ml/100 g/min) at rest and after vasodilation were correlated
with angiography.
Positron emission tomography. Subjects were studied af-
ter an overnight fast. All caffeinated beverages and
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theophylline-containing medications were withheld for at
least 24 h. The studies were performed on an ECAT
EXACT-47 whole-body scanner, which provides 47 con-
tiguous transaxial slices. The localization of the heart within
the axial field of view of the scanner was confirmed by
performing a 2-min transmission scan using a rotating
germanium-68/gallium-68 (68Ge/68Ga) rod source. Patient
positioning within the field of view of the camera was
indexed using laser cross beams and indelible marks on the
patient’s torso. The patients were instructed not to move
during data acquisition, and the location of the ink marks
relative to the laser cross beams on their torso was checked
frequently to ensure compliance. A 20-min transmission
scan with a rotating 68Ge/68Ga rod source was performed to
correct for attenuation.
Between 12 to 20 mCi of nitrogen-13 ammonia (13NH3)
was infused with a Harvard constant infusion pump over
30 s. Sequential dynamic frames were acquired for a total of
19 min (twelve 10-s frames, two 30-s frames, one 60-s
frame, and one 900-s frame).
After completion of the rest study, we allowed 30 to
60 min for the decay of 13NH3. Patients then received IV
dipyridamole (0.56 mg/kg) via a Harvard pump over 4 min.
Blood pressure and 12-lead ECGs were recorded every
minute during dipyridamole infusion and for an additional
4 min thereafter. Patients were repeatedly questioned about
symptoms following the onset of infusion of dipyridamole.
Episodes of chest pain that tended to mimic the patient’s
usual angina were noted. At the 8th min following the onset
of dipyridamole infusion, between 12 and 20 mCi of 13NH3
was infused over 30 s. Sequential dynamic imaging was
commenced simultaneously for 19 min using the framing
protocol outlined above. All patients with chest pain and/or
ST segment depression received IV aminophyline after the
first 2 min of data acquisition.
PET image analysis. Images were reconstructed with a
Hann filter with critical frequency of 0.4 cycles per pixel,
giving a spatial resolution of 10 mm in plane and 10 mm in
the axial direction. The transaxial images were corrected for
radionuclide decay and transferred to a Sun workstation for
processing. The transaxial slices acquired in the last frame
(900 s) were reoriented into eight short axis slices using
standard system software. Each of the short axis slices was
divided into eight myocardial sectors (each subtending 45
degrees). In addition, a 5 3 5-pixel region of interest
(1.3 cm3) was placed in the center of the left ventricular
blood pool in several basal slices and averaged to comprise
the input function. The sectors and the blood pool regions
of interest were copied onto the initial 12 frames (120 s of
data). Sectorial count data in these frames were used to
generate myocardial time-activity curves. The arterial tracer
input function was determined from the blood pool regions
of interest in these initial 12 frames. The tissue time-activity
curves were corrected for partial volume, assuming a wall
thickness of 1 cm (17). Separate correction was made for
blood-to-tissue activity spillover. Corrections were not
made for metabolites from the breakdown of tracer because
the quantitative analysis was limited to the data collected in
the first 120 s, during which metabolite contamination is
negligible (18). Myocardial blood flow quantitation (ml/
100 g/min) was performed by fitting the decay-corrected
time activity curves with a two-compartment model (19).
Sectorial absolute flows were calculated in eight basal to
midventricular short axis planes in each patient. Because
variances in sectorial blood flow values down the planes
were negligible, absolute blood flow in each sector was
averaged deep through the planes.
For display purposes, functional polar maps were con-
structed to display absolute myocardial perfusion and flow
reserve (Fig. 1). To construct these maps, which present
myocardial perfusion in ml/100 g/min, dynamic polar map
data were obtained from the system software, which uses
both short axis and long axis slices. Tissue time-activity
curves were then subjected to a nine-pixel averaging and
were also averaged one plane above, and one plane below,
the pixel of interest. This was repeated for all pixels. The
input function was obtained from short axis slices as above.
Definition of coronary steal. Coronary steal was defined
as an absolute decrease in blood flow from resting values in
a segment following vasodilation.
Analysis of the coronary angiograms. All patients under-
went coronary angiography using standard techniques
within six months of enrollment into the study. Experienced
observers who were blinded to the results of the PET
studies reviewed coronary angiograms. Visual estimates of
luminal narrowing of at least 50% in the left main artery and
75% in the other coronary vessels were considered signifi-
cant. Both the origin and the recipient vascular beds of
angiographic collaterals were noted. The vascular territories
on the perfusion scans were divided, using standard criteria.
Collateral territories were defined as those supplied by
collateral vessels in an area where the proximal vessel was
occluded or severely narrowed. Collateral vessels were iden-
tified by late contrast filling. Careful correlations of the
distribution and extent of noncollateralized and collateral-
ized myocardium were then transferred to the PET images
to co-localize these areas.
Abbreviations and Acronyms
ACE 5 angiotensin-converting enzyme
BP 5 blood pressure
CABG 5 coronary artery bypass grafting
CAD 5 coronary artery disease
LAD 5 left anterior descending artery
LCx 5 left circumflex artery
MBF 5 myocardial blood flow
13N 5 nitrogen-13
NH3 5 ammonia
PET 5 positron emission tomography
RCA 5 right coronary artery
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Analysis of the ECG. Observers who were blinded to the
results of the PET studies performed ECG analysis. The
occurrence of 0.1 mV horizontal or downsloping ST seg-
ment depression, 0.15 mV upsloping ST segment, 0.15 mV
additional ST segment depression when there were resting
ST segment depressions or the presence of 0.1 mV ST
Figure 1. Parametric polar map of myocardial perfusion at rest (left), after coronary vasodilation with dipyridamole (middle), and a map of myocardial
perfusion reserve (produced by a pixel-by-pixel division of the post-dipyridamole map by the resting map) in a patient with coronary steal (A) and a patient
without coronary steal (B). The color scale represents absolute myocardial perfusion (ml/100 g/min) in the flow map, and a relative ratio in the map of
myocardial perfusion reserve. Blood flow in the patient with steal decreases in absolute terms after dipyridamole, and myocardial perfusion reserve becomes
,1. Polar maps represent myocardial perfusion with anterior to the top, lateral to the reader’s right, inferior myocardium to the bottom, and septal
myocardium to the reader’s left. The apex is depicted in the center and the base at the periphery.
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segment elevation (in leads without Q-waves) were all
considered significant. All measurements were taken at
60 ms after the J point.
Statistical analysis. Numerical data are presented as
mean 6 SD. Myocardial perfusion reserve and the hemo-
dynamic and clinical variables were compared in patients
with and without coronary steal using the Student t-test.
The Fisher exact test and logistic regression analysis were
performed to test for a relationship between coronary steal
and the following variables: angina, ST depression, ST
elevation, combination of ST depression and angina, base-
line diastolic blood pressure (BP), hyperemic diastolic BP,
change in diastolic BP, baseline systolic BP, hyperemic
systolic BP, change in systolic BP, baseline rate-pressure
product, hyperemic rate-pressure product, change in rate-
pressure product, and change in heart rate.
RESULTS
Patient characteristics. The study population comprised
18 patients with severe symptomatic multivessel CAD
(Table 1). Seven patients had a prior history of myocardial
infarction; of these, six were Q-wave infarcts. No patient
had an infarct within six months of enrollment in the study.
Eight patients had a history of prior coronary artery bypass
grafting (CABG). All patients with bypass graft also had
evidence of significant graft stenosis on angiograms.
Coronary steal was noted in at least one myocardial
segment in 8 of the 18 patients studied. In these patients, by
definition, absolute myocardial blood flow (MBF) was
reduced in the segments defined as having coronary steal
following coronary vasodilation compared with rest. Figure
1 shows representative polar maps of myocardial perfusion
in two subjects—one with steal and one without evidence of
steal. No significant difference was seen between patients
with and without coronary steal in terms of age, gender,
extent of CAD, history of previous myocardial infarction,
history of previous CABG or use of anti-ischemia medica-
tions (Tables 1 and 2). The angiographic extent of CAD
was comparable between patients with and without cor-
onary steal with the exception of a higher prevalence of
angiographic collaterals in the patients with coronary steal
(Table 2).
Hemodynamic data. The results of the hemodynamic
response to dipyridamole infusion are summarized in Table
3. Mean heart rate in all subjects increased from 61 6 16
beats/min at baseline to 83 6 15 following dipyridamole.
Mean arterial pressure did not change significantly fol-
lowing dipyridamole compared with baseline. Mean double
product in all subjects increased from 9294 6 3444 mm
Hgzbeats/min to 11704 6 3144 mm Hg z beats/min (p 5
NS). Diastolic BP increased from 75 6 12 mm Hg at
baseline to 94 6 13 mm Hg following dipyridamole (p 5
0.05). No significant differences existed in hemodynamic
variables studied between patients with and without evi-
dence of coronary steal (Table 3).
Clinical and ECG findings. The ST segment depression
was noted in eight patients. The mean number of ECG
leads involved in the patients with ST depression was 2 6
3; ST segment elevation in leads without Q waves was noted
in five patients. The mean number of ECG leads with ST
elevation was 2 6 0.5. All patients with ST elevation had
ST depressions. The ST segment depressions did not
appear to be reciprocal to the elevations. Ten patients
Table 1. Clinical Characteristics in Patients With and Without
Coronary Steal
Patients With
Steal (n 5 8)
Patients Without
Steal (n 5 10)
p
Value
Age (yrs) 63 6 11 65 6 11 0.72
Male gender 8 7 0.09
Ejection fraction 48 44 0.64
Angina 6 6 0.50
Previous infarct 2 5 0.28
Previous CABG 3 5 0.59
Medications
Beta-blockers 5 2 0.07
Calcium antagonists 2 4 0.50
Nitrates 3 3 0.74
ACE inhibitors 1 1 0.87
Aspirin 4 4 0.67
ACE 5 angiotensin-converting enzyme; CABG 5 coronary artery bypass grafting.
Table 2. Angiographic Findings in Patients With and Without
Coronary Steal
Patients
With Steal
(n 5 8)
Patients
Without Steal
(n 5 10)
p
Value
Triple-vessel disease 7 6 NS
Double-vessel disease 1 3 NS
LAD stenosis (mean % stenosis) 8 (92) 9 (87) NS
LCx stenosis (mean % stenosis) 7 (82) 9 (84) NS
RCA stenosis (mean % stenosis) 8 (78) 8 (94) NS
100% occlusions 4 6 NS
Patients with angiographic
evidence of collaterals
8 4
LAD 5 left anterior descending artery; LCx 5 left circumflex artery; RCA 5 right
coronary artery.
Table 3. Hemodynamic Findings in Patients With and Without
Coronary Steal
Patients
With Steal
(n 5 8)
Patients
Without Steal
(n 5 10)
p
Value
Baseline diastolic BP 79 6 9 73 6 16 0.36
Hyperemic diastolic BP 82 6 10 75 6 15 0.26
Change in diastolic BP 3 6 9 2 6 13 0.83
Baseline rate-pressure
product
9615 6 2626 9037 6 4108 0.73
Hyperemic rate-pressure
product
11456 6 2016 11902 6 3926 0.77
Change in rate-pressure
product
1841 6 2587 2865 6 3731 0.52
Baseline systolic BP 151 6 20 140 6 31 0.41
Hyperemic systolic BP 143 6 19 140 6 36 0.83
Change in systolic BP 28 6 20 0 6 27 0.52
Change in heart rate 17 6 9 19 6 13 0.81
BP 5 blood pressure.
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complained of angina following dipyridamole (Table 4).
There was a significant difference in the occurrence of ST
elevation (p 5 0.002) and the combination of ST depression
and angina (p 5 0.04) between patients with and without
coronary steal. There was no significant difference between
the two groups in the prevalence of ST depression alone.
The incidence of angina alone following dipyridamole
infusion tended to be higher in the patients with coronary
steal (p 5 0.06).
Quantitation of coronary steal. Coronary steal was noted
in 8 of the 18 patients studied. Of the total 64 myocardial
regions (8 sectors per short axis plane averaged from base to
apex) in these eight patients, coronary steal was noted in 24
segments. Mean resting flow in these 24 segments was 90 6
18 ml/100 g/min. Following hyperemia, flow decreased
significantly to 68 6 27 ml/100 g/min (p , 0.001) instead
of the expected increase. Thus, absolute MBF in segments
with coronary steal decreased by 22 6 10 ml/100 g/min
(12 6 5%) following dipyridamole compared with baseline.
In the remaining 40 segments, flow increased from 87 6 19
ml/100 g/min at rest to 138 6 56 ml/100 g/min following
dipyridamole (Fig. 2). Myocardial flow reserve, which is the
ratio of hyperemic to rest flow, was 0.75 6 0.1 in segments
with steal and 1.6 6 0.3 in segments without steal (p ,
0.001).
A comparison of absolute MBF in patients with and
without coronary steal in at least one segment revealed a
higher resting flow in patients with coronary steal (89 6 25
and 75 6 21 ml/100 g/min in patients with and without
steal, respectively (p 5 0.01). Mean hyperemic flow was
significantly lower in patients with steal than in patients
without steal, 114 6 67 vs. 144 6 57 ml/100 g/min,
respectively (p , 0.001; Fig. 2). Mean myocardial perfusion
reserve in patients with coronary steal was 1.3 6 0.2
compared with 1.9 6 0.3 in patients without steal (p ,
0.001).
Angiographic correlation. Twelve of 18 patients had an-
giographic evidence of collaterals. Coronary steal was iden-
tified only in patients with angiographic evidence of collat-
erals. Thus, of the eight patients who demonstrated
coronary steal defined with PET, all had angiographic
evidence of collateral circulation. In comparison, in the 10
patients without coronary steal, only 4 had evidence of
collateral circulation (p 5 0.04) (Table 3). The collateral
supply in six of eight patients with coronary steal and four of
four patients without coronary steal were qualitatively as-
sessed as “good.” All myocardial segments with absolute
decreases in flow following induction of hyperemia, com-
pared with rest, had corresponding angiographic evidence of
collaterals. Eight of these 24 segments were in territories
supplied by vessels with total occlusions.
Clinical correlates of coronary steal. Table 5 shows the
significant clinical correlates of coronary steal. The combi-
nation of ST segment depression with the patients’ typical
angina, and ST segment elevation, were the only significant
clinical correlates of coronary steal on univariate analysis.
The ST segment depression alone did not correlate with
coronary steal. The relationship between angina alone and
coronary steal was marginal (p 5 0.06). There was no
relationship between presence of coronary steal and any of
the hemodynamic variables tested.
Of all the variables tested, ST segment elevation in any
lead was most strongly correlated with steal (p 5 0.006). On
stepwise logistic regression, the addition of other variables
did not significantly improve the relationship between ST
elevation and coronary steal.
DISCUSSION
Coronary steal has been well described in animal studies
(15,16). It is believed to be due to a decrease in supply via
collaterals to dependent myocardium following coronary
Figure 2. Histogram of myocardial perfusion in hearts from patients who
exhibited steal in at least one segment. In these patients, as depicted,
myocardial perfusion at rest in segments with and without steal was
equivalent. However, after dipyridamole, segments with steal exhibited an
absolute reduction in perfusion, whereas segments without steal vasodilated
to similar levels as those observed in patients without steal. Open bars:
segments with steal (n 5 24); solid bars: segments without steal (n 5 40).
Table 4. Clinical and Electrocardiographic Findings During
Coronary Vasodilation in Patients With and Without Coronary
Steal
Patients
With Steal
(n 5 8)
Patients
Without Steal
(n 5 10)
p
Value
Angina 6 4 0.06
Patients with ST depression 5 3 0.16
Patients with ST depression
and angina
4 1 0.04
Mean No. of ECG leads
with ST depression
2 6 3 1 6 2 0.17
No. of patients with
ST elevation
5 0 , 0.001
ECG 5 electrocardiogram.
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vasodilation (12). The cause is diminished driving pressure
at the proximal end of the collateral vessels due to decreased
resistance in the supplying, conductance artery as well as a
nominal or blunted fall in resistance in the collateral circuit
(16). Consequently, we specifically selected patients with
advanced multiple-vessel CAD in order to maximize our
chances of eliciting the coronary steal phenomenon.
Absolute quantification of coronary steal. Our results in
this population of patients with multivessel CAD show that
the magnitude of coronary steal is quite significant. Abso-
lute myocardial blood in the affected segments decreased by
22 6 10 ml/100 g/min. Rest flow was also noted to be
significantly higher in patients with coronary steal than in
those without steal. The increased resting flow in patients
with steal might be attributable to the higher double
product in these patients (although not statistically signifi-
cant). In addition, a difference in wall stress, which was not
measured in this study, could account for the difference in
resting flow between the two groups. Mean myocardial
perfusion reserve in the segments with coronary steal in our
study (0.75 6 0.18) is consistent with the observation of a
coronary flow reserve velocity ratio of 0.7 in collateralized
myocardium, following infusion of adenosine, reported by
Seiler et al. using invasive techniques (20). In addition, this
magnitude is consistent with changes in myocardial perfu-
sion following pharmacologic vasodilation reported by other
investigators (21–23). Baliga et al. (21) demonstrated a 25%
decrease in blood flow to regions supplied by stenotic
coronary arteries in patients with postprandial angina. The
reduction in flow was presumably due to redistribution of
flow away from the diseased regions.
Other investigators have also demonstrated comparable
magnitudes of coronary steal by PET measured semiquan-
titatively (12,24). In those studies, coronary steal was
defined as a decrease in regional tracer counts following
pharmacologic vasodilation compared with rest counts.
Garza et al. (24) noted a hyperemia/rest count ratio of 0.8 in
patients with coronary collaterals following infusion of
dipyridamole, and Demer et al. (12) demonstrated a mean
decrease of 15% in counts following induction of hyperemia
compared with rest in collateralized myocardium. However,
in these semiquantitative studies, absolute flow quantitation
was not performed.
Skopicki et al. (23) demonstrated an absolute decline in
myocardial perfusion in patients with collateralized myocar-
dium, using PET and 13NH3. In their study, flow in normal
segments increased from 90 to 310 ml/100 g/min, whereas
flow in segments with steal decreased from 92 to 50 ml/100
g/min. Severi et al. (22) similarly demonstrated that myo-
cardial segments that develop a wall-motion abnormality in
response to dobutamine have an absolute decrease in myo-
cardial perfusion when assessed with oxygen-15–labeled
water.
Our results contrast with the findings in the study by
McFalls et al. (25), which showed increased flow relative to
baseline in collateralized myocardium following infusion of
dipyridamole. The absence of an absolute decrease in flow to
collateralized myocardium in their study might have been
due to the fact that only patients with single-vessel CAD
were studied. As demonstrated in studies in animals by
Becker (16), for coronary steal to occur, it is important to
have some degree of stenosis in the donor vessel proximal to
the origin of the collaterals in addition to the stenosis in the
recipient vascular bed. Thus, coronary steal will tend to
occur mainly in the presence of multivessel CAD.
It should be recognized that even in segments that do not
exhibit coronary steal, vasodilator reserve is abnormal. This
is consistent with findings in patients with ischemic heart
disease.
Clinical correlates of coronary steal. Of all the variables
tested, only the combination of ST segment depression and
angina (p 5 0.040) or ST elevation (p 5 0.006) correlated
with coronary steal. The ST segment depression alone did
not correlate with coronary steal. Furthermore, the relation-
ship between angina alone and coronary steal was marginal
(p 5 0.06). The other variables, including extent of CAD,
Table 5. Correlates of Coronary Steal
p
Value
Sensitivity
(%)
Specificity
(%)
Positive
Predictive
Value (%)
Negative
Predictive
Value (%)
ST elevation , 0.001 63 100 100 77
Angina with ST depression 0.04 71 90 80 82
Angina 0.06
ST depression NS
Baseline rate-pressure product NS
Hyperemic rate-pressure product NS
Change in rate-pressure product NS
Baseline diastolic BP NS
Hyperemic diastolic BP NS
Change in diastolic BP NS
Baseline heart rate NS
Hyperemic heart rate NS
Change in heart rate NS
BP 5 blood pressure.
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baseline rate-pressure product, hyperemic rate-pressure
product, change in rate-pressure product, and baseline,
hyperemic and change in diastolic pressure and heart rate
did not correlate with coronary steal.
The ST segment elevation during pharmacologic stress
testing is a highly specific but insensitive marker of severe
CAD. The presence of ST elevation during exercise gener-
ally signifies transmural ischemia. Thus, the relatively high
incidence of ST elevation in this study is most likely due to
the fact that we studied only patients with severe multivessel
CAD.
Our findings support the routine administration of IV
aminophyline to reverse the effects of dipyridamole in all
patients with either ST elevation or the combination of
angina and ST depression, given their strong correlation
with coronary steal.
Previous studies have shown a relationship between ST
segment depression during vasodilator-induced hyperemia
and the following variables: decrease in arterial BP (26),
increase in rate-pressure product (27), triple-vessel disease
(27), presence of collaterals (3,14,26), systolic BP at baseline
(14), and angina (14). These studies used ST segment
depression during hyperemia as a marker of ischemia and,
consequently, coronary steal. However, using decreases in
absolute flow from rest to define ischemia, we found a
relationship between ST segment depression and coronary
steal only when the former is accompanied by angina. Thus,
our data suggest that either the combination of ST depres-
sion and angina or ST elevation should be used as clinical
evidence of ischemia during dipyridamole infusion rather
than ST depression alone.
All of the hemodynamic variables studied, including
change in rate-pressure product, systolic BP at baseline and
decrease in diastolic BP did not correlate with coronary
steal. Thus, it is unlikely that the mechanism of the
observed reduction in flow following induction of hyper-
emia is related to a decrease in perfusion pressure of the
entire coronary circulation.
Study limitations. The limitations of this study should be
recognized: First, the study size was small and selected for
patients with severe CAD. Thus, the sample might not
represent the average population of patients referred for
pharmacologic stress testing. Second, matched normal con-
trols were not studied.
Conclusions. In conclusion, coronary vasodilation with IV
dipyridamole is associated with a significant absolute reduc-
tion in blood flow to collateral-dependent myocardium
consistent with coronary steal. The combination of angina
and ST depression and ST elevation were the only clinical
correlates of coronary steal.
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